Technology News and Research

RSS

Stereotaxis to highlight results from Epoch clinical study at HRS annual meeting

Stereotaxis, Inc. will highlight clinical results from the first 1,250 cases and the latest innovations for the Epoch platform, its new generation comprehensive solution for the electrophysiology (EP) laboratory, at the 33rd Annual Heart Rhythm Society (HRS) Scientific Sessions, May 9-12, 2012.

8 May 2012

Solazyme first quarter total revenue increases to $13.6 million

Solazyme, Inc., a renewable oil and bioproducts company, announced today financial results for the first quarter ended March 31, 2012 and recent key corporate highlights.

8 May 2012

CardioFocus’ HeartLight EAS to be highlighted at Heart Rhythm 2012

CardioFocus, Inc., developer of the HeartLight® Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF), announces that its technology will be highlighted both as part of the scientific sessions and during a private academic symposium at Heart Rhythm 2012, the Heart Rhythm Society's 33rd Annual Scientific Sessions, May 9-12 in Boston, MA.

8 May 2012

Pall in-line filters can reduce severe complications, length of hospital stay in PICU

A recently published clinical study on infusion therapy indicates in-line filters from Pall Corporation can reduce severe complications and the length of a patient's stay in the pediatric intensive care unit.

From Pall Corporation 8 May 2012

Energetiq launches EQ-99CAL laser-driven light source

Energetiq Technology, Inc., a developer and manufacturer of ultrahigh-brightness, broadband light sources for advanced technology applications, today introduced a new light source to its established line of LDLS Laser-Driven Light Sources for use in radiometric calibration.

8 May 2012

NCPIE launches three acetaminophen safe use modules

The National Council on Patient Information and Education (NCPIE) today launched three customized, online educational modules to promote safe use of acetaminophen products.

8 May 2012

New data from Acucela’s ACU-4429 Phase 2a trial on advanced dry AMD/geographic atrophy

Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that the first patient data from the ACU-4429 program were presented during a poster session at The Association for Research in Vision and Ophthalmology (ARVO) 2012 Annual Meeting.

8 May 2012

KSW releases Krames On-Demand Version 6.0

Krames StayWell (KSW) has announced the newest release of its award-winning patient education program Krames On-Demand Version 6.0.

8 May 2012

Clinverse closes $3.8 million Series B round of funding

Clinverse, Inc., the global cloud-based ecommerce platform provider for clinical trials, announced today that it has closed a $3.8 million Series B round of funding led by Hatteras Venture Partners of Durham, NC. Vital Financial of Bethesda, MD, also participated in this funding round.

8 May 2012

Zinc oxide could increase risk of skin cancer

As vacationers prepare to spend time outdoors this summer, many of them will pack plenty of sunscreen in hopes it will protect their bodies from overexposure, and possibly from skin cancer. But researchers at Missouri University of Science and Technology are discovering that sunscreen may not be so safe after all.

8 May 2012

Hologic features minimally invasive technologies at ACOG annual clinical meeting

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, is featuring minimally invasive technologies in surgical, diagnostic and skeletal health at The American College of Obstetricians and Gynecologists (ACOG) annual clinical meeting.

From Hologic, Inc. 7 May 2012

Comprehensive mobile stroke ambulance

NeuroLogica Corporation and German based MEYTEC GmbH announced today the development of the world's first comprehensive mobile stroke ambulance. Stroke-Emergency-Mobile, VIMED STEMO, combines MEYTEC's cutting-edge telemedicine solutions with NeuroLogica's state of the art portable CT scanner, CereTom.

7 May 2012

Monteris secures financing to commercialize NeuroBlate System

Monteris Medical Inc., a privately held medical device company dedicated to the development of innovative MRI guided, laser-based cancer treatments announced today it has secured $9 million in financing to support the continued commercialization of the company's NeuroBlate System (formerly AutoLITT) within the North American neurosurgery market.

7 May 2012

Fluidigm offers unrestricted sales of digital PCR and non-invasive prenatal diagnostics

Fluidigm Corporation today announced that it can now offer unrestricted sales of its digital PCR and other advanced technology to customers interested in pursuing research and product development into the prenatal health and non-invasive prenatal diagnostics fields, as well as other fields.

7 May 2012

Claraview reports successful deployment of Enterprise Data Integrity solution for Affinity Health Plan

Claraview, a division of Teradata, a strategy and technology consultancy focused exclusively on business intelligence (BI) and analytic solutions, announced today the successful deployment of the Enterprise Data Integrity (EDI) solution for Affinity Health Plan.

7 May 2012

Latest science from area of network biology

This week experts from around the world will meet to discuss how network models can be applied to the study and targeting of complex diseases such as cancer, diabetes and neurological disorders.

7 May 2012

Emdeon expands healthcare payment integrity solutions with TC3 acquisition

Emdeon Inc., a leading provider of healthcare revenue and payment cycle management and clinical information exchange solutions, today announced its acquisition of TC3Health, Inc. The acquisition of TC3 expands Emdeon's already robust Payment Integrity solutions for healthcare payers to include new claims analytics tools from pre-adjudication through post-payment, as well as access to a broad out-of-network claims cost management solution.

7 May 2012

Chesapeake Regional Medical Center rolls out automated disinfection robot

Chesapeake Regional Medical Center rolled out the newest member of its environmental team last week, a five-foot, automated disinfection robot named Tru-D (Total Room Ultraviolet Disinfection). Implementation of the mobile, high-tech disinfection device is part of a $2 million CDC grant awarded to Duke University for the prevention of healthcare-associated infections (HAI's).

7 May 2012

Keryx, Aeterna Zentaris execute perifosine license termination and technology transfer agreement

Keryx Biopharmaceuticals, Inc. today announced that the Company and Aeterna Zentaris Inc. have executed a License Termination and Technology Transfer Agreement, whereby the KRX-0401 (perifosine) license agreement has been terminated and all license rights have reverted back to Aeterna Zentaris.

7 May 2012

Kerberos to put Rinspiration Thrombectomy System up for bid

Co-Founders of Kerberos Proximal Solutions, Inc., announced today that, during the upcoming Paris Course on Revascularization, they plan to actively engage in discussions to put the company's proprietary Rinspiration technology platform up for bid, seeking buyers with complementary portfolios and distribution channels.

7 May 2012